Financial Year |
March 31 2023 |
Monetary Funds |
998,261,785.83 |
Held-for-trading Financial Assets |
863,500,438.36 |
Notes Receivable |
585,523,321.00 |
Accounts Receivable |
3,601,303.38 |
Advances to Suppliers |
37,520,433.58 |
Other Receivables |
12,078,745.41 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
4,428,044,765.25 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
41,506.63 |
Total Current Assets |
6,928,572,299.44 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
-- |
Investment Properties |
106,937,534.54 |
Fixed Assetes |
2,659,568,725.58 |
Under-construction Projects |
1,276,369,440.41 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
511,569,751.92 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
-- |
Deferred Income Tax Assets |
26,947,861.61 |
Other Non-Current Assets |
273,388,459.59 |
Sub-Total of Non-Current Assets |
4,856,459,534.15 |
Total Assets |
11,785,031,833.59 |
Short-Term Loans |
-- |
Trading Financial liabilities |
-- |
Notes Payable |
444,170,000.00 |
Accounts Payable |
412,731,600.36 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
11,088,174.85 |
Taxes Payable |
261,185,742.00 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
573,419,801.41 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
2,022,757.12 |
Other Current Liabilities |
17,225,157.71 |
Sub-Total of Current Liabilities |
2,167,114,742.30 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
101,438,771.68 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
177,987,822.46 |
Total Liabilities |
2,345,102,564.76 |
Paid-In Capital(Or Share Stock) |
600,000,000.00 |
Capital Surplus |
976,882,369.04 |
Surplus Reserve |
359,594,123.61 |
LESS:Treasury Stock |
148,931,302.87 |
Undistributed Profits |
7,652,384,079.05 |
Minority Stockholder's Interest |
-- |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
9,439,929,268.83 |
Owner's Equity(Stockholder's Equity) |
9,439,929,268.83 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
11,785,031,833.59 |